Healthcare -
Biotechnology - NASDAQ - US
$ 32.14
-2.28 %
$ 1.86 B
Market Cap
-25.11
P/E
JANX - COST OF REVENUE
Cost of Revenue JANX - Janux Therapeutics, Inc.
1.96 M
LAST VALUE
315.94%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR